Exosome Diagnostics
Commercializing minimally invasive molecular diagnostics in blood and urine to enable doctors to select optimal therapies for cancer and other diseases. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
CAD164—245m (Dealroom.co estimates Jul 2017.)
Waltham Massachusetts (HQ)
Authorizing premium user...